Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: A five-year study

International Journal of Infectious Diseases

Volumn 39, Issue , 2015, Pages 1-6

  Denis, B ^a,b   Lafaurie, M ^a   Donay, J L ^a   Fontaine, J P ^a   Oksenhendler, E ^a   Raffoux, E ^a   Hennequin, C ^a   Allez, M ^a   Socie, G ^a   Maziers, N ^a   Porcher, R ^a   Molina, J M ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

Author keywords

Bacteraemia; ESBL Escherichia coli; Hospital stay; Mortality

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; CLINICAL FEATURE; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; RISK FACTOR; BACTEREMIA; CASE CONTROL STUDY; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CASE-CONTROL STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84940534986     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.07.010     Document Type: Article

References (19)

1. Rodríguez-Baño J., Navarro M.D., Romero L., Muniain M.A., de Cueto M., Ríos M.J., et al. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006, 43:1407-1414.
2. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
3. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
4. Rodríguez-Baño J., Navarro M.D., Romero L., Muniain M.A., de Cueto M., Gálvez J., et al. Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect 2008, 14:180-183.
5. Reddy P., Malczynski M., Obias A., Reiner S., Jin N., Huang J., et al. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007, 45:846-852.
6. Harris A.D., McGregor J.C., Johnson J.A., Strauss S.M., Moore A.C., Standiford H.C., et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007, 13:1144-1149.
7. Gudiol C., Calatayud L., Garcia-Vidal C., Lora-Tamayo J., Cisnal M., Duarte R., et al. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 2010, 65:333-341.
8. Rodríguez-Baño J., Picón E., Gijón P., Hernández J.R., Cisneros J.M., Peña C., et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol 2010, 48:1726-1731.
9. García Hernández A., García-Vázquez E., Gómez Gómez J., Canteras M., Hernandez-Torres A., Ruiz Gómez J. [Predictive factors of ESBL versus non-ESBL Escherichia coli bacteraemia and influence of resistance on the mortality of the patients]. Med Clin (Barc) 2011, 136:56-60.
10. Gudiol C., Tubau F., Calatayud L., Garcia-Vidal C., Cisnal M., Sánchez-Ortega I., et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 2011, 66:657-663.
11. Peralta G., Sánchez M.B., Garrido J.C., De Benito I., Cano M.E., Martínez-Martínez L., Roiz M.P. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 2007, 60:855-863.
12. Marchaim D., Gottesman T., Schwartz O., Korem M., Maor Y., Rahav G., et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2010, 54:5099-5104.
13. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
14. Cavallo J.D., Mérens A. [Antibacterial spectrum of an antibiotic and clinical categorization]. Pathol Biol 2008, 56:300-304.
15. Drieux L., Brossier F., Sougakoff W., Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008, 14(Suppl 1):90-103.
16. Giske C.G., Monnet D.L., Cars O., Carmeli Y. Clinical and economic impact of common multidrug-resistant Gram-negative bacilli. Antimicrob Agents Chemother 2008, 52:813-821.
17. Arnan M., Gudiol C., Calatayud L., Liñares J., Dominguez M.Á., Batlle M., et al. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2011, 30:355-360.
18. Rottier W.C., Ammerlaan H.S., Bonten M.J. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 2012, 67:1311-1320.
19. Peralta G., Lamelo M., Alvarez-García P., Velasco M., Delgado A., Horcajada J.P., et al. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis 2012, 12:245.